Gregory J. Divis - 06 Dec 2024 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role: Chief Executive Officer, Director
Signature: /s/ Jerad G. Seurer, as Attorney-in-Fact
Issuer symbol: AVDL
Transactions as of: 06 Dec 2024
Net transactions value: +$99,707
Form type: 4
Filing time: 10 Dec 2024, 18:14:56 UTC
Previous filing: 04 Mar 2024
Next filing: 07 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVDL	Ordinary Shares	Purchase	$95,759	+9,598		$9.98	9,598	06 Dec 2024	By Trust	F1, F2
transaction	AVDL	Ordinary Shares	Purchase	$3,948	+402	+4.2%	$9.82	10,000	09 Dec 2024	By Trust	F2
holding	AVDL	Ordinary Shares						159,100	06 Dec 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.925 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2	These Ordinary Shares are held by the Gregory J. Divis Jr. Revocable Trust, of which the Reporting Person is trustee and beneficiary.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.925 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

These Ordinary Shares are held by the Gregory J. Divis Jr. Revocable Trust, of which the Reporting Person is trustee and beneficiary.